| Agape Care Community Llc | |
| 12500 E Iliff Ave Ste 200, Aurora, Colorado 80014 | |
| (303) 368-7200 | |
| Not Available |
| Name | Agape Care Community Llc |
|---|---|
| Location | 12500 E Iliff Ave Ste 200, Aurora, Colorado |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Home Health Aide |
| Medicare ID | 67495 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 80011, 80012, 80013, 80014, 80016, 80017, 80102, 80120, 80202, 80205, 80211, 80219, 80220, 80229, 80239, 80246, 80247 |
| NPI Number | 1285946418 |
| Organization Name | AGAPE CARE COMMUNITY LLC |
| Address | 12500 E Iliff Ave Ste 200, Aurora, CO 80014 |
| Phone Number | 303-368-7200 |
News Archive
A drug prescribed to millions of patients in the U.S. as a treatment for Parkinson's disease and other conditions, has allegedly turned some patients into gambling addicts.
Noting the release of the Institute of Medicine's PEPFAR evaluation and "our own work-in-progress on PEPFAR's value for money and data management," Victoria Fan, a research fellow at the Center for Global Development (CGD), and Rachel Silverman, a research assistant at CGD, highlight "two focus areas that ... are the subject of a forthcoming CGD policy paper on PEPFAR's financial flows" in a post on CGD's "Global Health Policy" blog.
Gland Pharma Limited, a leading Indian pure-play generic injectable pharmaceutical products company, today announced an agreement under which KKR, a leading global investment firm, will acquire a minority stake in the Company for approximately US$200 million, including KKR's acquisition of the entire stake held by Evolvence India Life Sciences Fund, an existing private equity investor in Gland Pharma.
The New York Times has examined efforts by the pharmaceutical company Abraxis BioScience to obtain FDA approval for its late-stage breast cancer drug Abraxane as a treatment for earlier-stage breast cancer.
› Verified 3 days ago
| Quality Rating: | Not Available* |
| * The number of patient episodes for this measure is too small to report. | |
News Archive
A drug prescribed to millions of patients in the U.S. as a treatment for Parkinson's disease and other conditions, has allegedly turned some patients into gambling addicts.
Noting the release of the Institute of Medicine's PEPFAR evaluation and "our own work-in-progress on PEPFAR's value for money and data management," Victoria Fan, a research fellow at the Center for Global Development (CGD), and Rachel Silverman, a research assistant at CGD, highlight "two focus areas that ... are the subject of a forthcoming CGD policy paper on PEPFAR's financial flows" in a post on CGD's "Global Health Policy" blog.
Gland Pharma Limited, a leading Indian pure-play generic injectable pharmaceutical products company, today announced an agreement under which KKR, a leading global investment firm, will acquire a minority stake in the Company for approximately US$200 million, including KKR's acquisition of the entire stake held by Evolvence India Life Sciences Fund, an existing private equity investor in Gland Pharma.
The New York Times has examined efforts by the pharmaceutical company Abraxis BioScience to obtain FDA approval for its late-stage breast cancer drug Abraxane as a treatment for earlier-stage breast cancer.
› Verified 3 days ago
News Archive
A drug prescribed to millions of patients in the U.S. as a treatment for Parkinson's disease and other conditions, has allegedly turned some patients into gambling addicts.
Noting the release of the Institute of Medicine's PEPFAR evaluation and "our own work-in-progress on PEPFAR's value for money and data management," Victoria Fan, a research fellow at the Center for Global Development (CGD), and Rachel Silverman, a research assistant at CGD, highlight "two focus areas that ... are the subject of a forthcoming CGD policy paper on PEPFAR's financial flows" in a post on CGD's "Global Health Policy" blog.
Gland Pharma Limited, a leading Indian pure-play generic injectable pharmaceutical products company, today announced an agreement under which KKR, a leading global investment firm, will acquire a minority stake in the Company for approximately US$200 million, including KKR's acquisition of the entire stake held by Evolvence India Life Sciences Fund, an existing private equity investor in Gland Pharma.
The New York Times has examined efforts by the pharmaceutical company Abraxis BioScience to obtain FDA approval for its late-stage breast cancer drug Abraxane as a treatment for earlier-stage breast cancer.
› Verified 3 days ago
Aveanna Healthcare Location: 12100 E Iliff Ave Ste A-250, Aurora, Colorado 80014 Ratings: NA Phone: (303) 363-4107 | |
At Home Healthcare Location: 2675 S Abilene St Suite 290, Aurora, Colorado 80014 Ratings: Phone: (303) 369-7063 | |
Essential Medical Services Inc Location: 3000 S Jamaica Ct #175, Aurora, Colorado 80014 Ratings: NA Phone: (303) 873-0941 | |
Berkley Home Health Location: 10697 E Dartmouth Avenue, Aurora, Colorado 80014 Ratings: Phone: (303) 758-2000 | |
Golden Harmony Inc Location: 14707 East 2nd Avenue Suite 200, Aurora, Colorado 80011 Ratings: NA Phone: (303) 375-9250 | |
Amazing Care Home Health Services Location: 2821 South Parker Road Suite 615, Aurora, Colorado 80014 Ratings: Phone: (303) 755-3170 |